Molecular imaging using PET for breast cancer

被引:16
|
作者
Kurihara, Hiroaki [1 ]
Shimizu, Chikako [2 ]
Miyakita, Yasuji [3 ]
Yoshida, Masayuki [4 ]
Hamada, Akinobu [5 ]
Kanayama, Yousuke [6 ]
Yonemori, Kan [2 ]
Hashimoto, Jun [2 ]
Tani, Hitomi [1 ]
Kodaira, Makoto [2 ]
Yunokawa, Mayu [2 ]
Yamamoto, Harukaze [2 ]
Watanabe, Yasuyoshi [6 ]
Fujiwara, Yasuhiro [2 ]
Tamura, Kenji [2 ]
机构
[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan
[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan
关键词
Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;
D O I
10.1007/s12282-015-0613-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 50 条
  • [1] Molecular imaging using PET for breast cancer
    Hiroaki Kurihara
    Chikako Shimizu
    Yasuji Miyakita
    Masayuki Yoshida
    Akinobu Hamada
    Yousuke Kanayama
    Kan Yonemori
    Jun Hashimoto
    Hitomi Tani
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    Breast Cancer, 2016, 23 : 24 - 32
  • [2] Molecular imaging using PET and SPECT for identification of breast cancer subtypes
    Liu, Hao
    Chen, Yao
    Wu, Shuang
    Song, Fahuan
    Zhang, Hong
    Tian, Mei
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) : 1116 - 1124
  • [3] Application of PET Tracers in Molecular Imaging for Breast Cancer
    Boers, Jorianne
    de Vries, Erik F. J.
    Glaudemans, Andor W. J. M.
    Hospers, Geke A. P.
    Schroeder, Carolina P.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (08)
  • [4] Novel Molecular Classification of Breast Cancer with PET Imaging
    Toan, Ngo Minh
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [5] Application of PET Tracers in Molecular Imaging for Breast Cancer
    Jorianne Boers
    Erik F. J. de Vries
    Andor W. J. M. Glaudemans
    Geke A. P. Hospers
    Carolina P. Schröder
    Current Oncology Reports, 2020, 22
  • [6] Molecular imaging of cancer using PET and SPECT
    Kjaer, Andreas
    New Trends in Cancer for The 21st Century, 2nd Edition, 2006, 587 : 277 - 284
  • [7] FDG-PET and beyond: Molecular breast cancer imaging
    Quon, A
    Gambhir, SS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1664 - 1673
  • [8] PET imaging in breast cancer
    Bombardieri, E
    Crippa, F
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2001, 45 (03): : 245 - 256
  • [9] PET Imaging for Breast Cancer
    Fowler, Amy M.
    Cho, Steve Y.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2021, 59 (05) : 725 - 735
  • [10] PET Imaging and Breast Cancer
    Gemignani, Mary L.
    ONCOLOGY-NEW YORK, 2014, 28 (05): : 430 - +